Professional Documents
Culture Documents
Radiofrequency Ablation in Nodular Thyroid Diseases: Ming-Tsang Lee, Chih-Yuan Wang
Radiofrequency Ablation in Nodular Thyroid Diseases: Ming-Tsang Lee, Chih-Yuan Wang
REVIEW ARTICLE
1
Division of Endocrinology, Department of Internal Medicine, Far-Eastern Memorial Hospital, and
2
Department of Internal Medicine, National Taiwan University Hospital, College of Medicine,
National Taiwan University, 7, Chung-Shan South Road, Taipei, Taiwan, ROC
KEY WORDS Radiofrequency ablation is a minimally invasive technique that can produce tissue coagulation
minimally invasive, necrosis effectively and safely in humans with ultrasound or computed tomography guidance.
nodular goiter, The most frequent treatment site for radiofrequency ablation to date is the liver for hepato-
radiofrequency cellular carcinoma. Reviewing the history of radiofrequency ablation, we can see the evalua-
ablation, tion of electrodes from conventional monopolar electrode to multiprobe arrays, hook
thyroid cancer expandable electrodes, and internally cooled electrodes. All of these are trying to ablate
the tumor more widely and completely. From history, we also notice that the target can range
from heart, neurological disorders, and thyroid diseases to a variety of other diseases, in addi-
tion to liver malignancy. Studies have already shown that radiofrequency ablation is an excel-
lent alternative treatment for nodular thyroid disease, including benign and malignant lesions.
For treatment of recurrent well-differentiated thyroid cancer, radiofrequency ablation has
shown good results, such as no recurrence at treatment sites or reduced serum thyroglobulin
level. The possible complications include hoarseness, hematoma, severe pain, esophageal
perforation, or tracheal perforation. The reported rate for major complications in previous
studies is low. Therefore, if the patients have severe comorbidity that is not suitable for reo-
peration for thyroid malignancy, radiofrequency ablation is a good alternative. Furthermore,
radiofrequency ablation can be used for benign thyroid nodules to relieve local compressive
symptoms. Some patients who receive such treatment for cosmetic reasons also show a satis-
factory outcome. Here, we review previous studies about radiofrequency ablation in nodular
thyroid disease in many aspects, such as ablation system, ablation techniques, ablation effi-
cacy, and complications, both in benign thyroid nodules and recurrent thyroid cancer.
ª 2013, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.
* Correspondence to: Dr Chih-Yuan Wang, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine,
National Taiwan University, 7, Chung-Shan South Road, Taipei, Taiwan, ROC.
E-mail address: cyw1965@gmail.com (C.-Y. Wang).
0929-6441 ª 2013, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
http://dx.doi.org/10.1016/j.jmu.2013.04.006
Radiofrequency Ablation in Nodular Goiters 63
Application of radiofrequency to heart, liver, ablation in benign thyroid nodules, ranging from solid,
and thyroid gland mixed, cystic to autonomously functioning nodules. The
reviews and comparisons of these studies in malignant or
benign lesions are discussed in the following sections.
The earliest experience of radiofrequency ablation was to
ablate the aberrant neurofibril bundle in symptomatic car-
diac arrhythmia [17]. It was also introduced for the treatment Radiofrequency ablation in recurrent thyroid
of hyperactive neurologic foci or other neurologic disorders cancer
[18]. In such diseases, it only needs creation of a precise small
region of coagulation. Thus, the earlier conventional Papillary thyroid cancer, the most common subtype of thy-
monopolar single electrode is adequate for that purpose. The roid cancer, has a good prognosis after standard treatment
ablation technique has then been used to treat a diversity of of surgery followed by radioiodine therapy and adequate
neoplasms, such as osteoid osteoma, primary and metastatic thyroid hormone replacement. However, some patients may
liver tumor, renal cell carcinoma, prostate cancer, and breast have recurrent cancer in the previous surgical bed or
cancer percutaneously under the guidance of images, or metastasis to local regional lymph nodes. If the recurrent
intraoperatively. In the past two decades, the principal use of disease is resistant to radioiodine therapy or difficult to
radiofrequency ablation was for liver malignancies, both reoperate due to scar tissue formation or multiple comor-
primary and secondary. A lot of research related to the bidity, radiofrequency ablation could be a good alternative.
development and improvement of radiofrequency tech- Four studies [25e28] have shown encouraging results
niques to treat liver cancer with satisfactory results has been about radiofrequency ablation for local recurrent or met-
published [19]. The strategy to destroy a malignant lesion astatic well-differentiated thyroid cancer. The baseline
completely is different from the treatment of cardiac tumor sizes ranged from 1.38 cm to 2.9 cm in diameter.
arrhythmia. This means that the ablation-induced necrosis Radiofrequency ablation reduced the tumor volume and
covers the entire tumor and should also reach cytotoxic serum thyroglobulin level significantly in most patients in
temperatures to kill all cancer cells. Therefore, the evolution these studies. Baek et al [28] have reported a best average
of electrodes mentioned in the previous section is just to fit in volume reduction rate of 89.7%, with an average largest
with the requirement for complete ablation. diameter reduction rate of 76.1%. All researchers have
Benign or malignant nodular thyroid diseases are com- adopted the Radionics Cool-tip system as their ablation
mon. The prevalence of thyroid nodules has been reported system. This system is equipped with an internally cooled
as 4e8% of adults by palpation, 10e41% by ultrasound ex- electrode, with different lengths of the active tip ranging
amination, and 50% by pathologic examination at autopsy from 1 cm to 2 cm. The tumor sizes were relatively small
[20]. Local surveillance in Taiwan has also shown that adult compared with hepatocellular carcinoma, therefore, the
goiter prevalence was 19.4% in men, 33.6% in women, and longer active tip with a larger ablation zone was not
estimated to be 25% in the total population [21]. If the absolutely an advantage. On the contrary, the shorter
nodule is malignant or benign but causes compressive active tip may prevent damage to organs adjacent to the
symptoms, surgery is usually a better choice to remove the thyroid gland, such as the esophagus or recurrent laryngeal
nodule effectively. If the patient has primary thyroid cancer, nerve. For that reason, no researcher has used hooked
surgery is always the first choice. In some situations, if electrodes or clustered electrodes as the ablation tool.
recurrent thyroid cancer is detected several years after Baek et al [28] have introduced an electrode produced by
primary surgical intervention, but the patient is not suitable Taewoong Medical, Seoul, Korea, which only has a 0.5 cm
for another session of surgery due to comorbidity, a active tip in the electrode. In that way, the ablation could
nonsurgical and minimally invasive treatment modality is be performed more safely by easily handling the electrode.
needed as an alternative. When it refers to benign thyroid In two earlier studies [25,26], patients received intrave-
nodule but with compressive symptoms, surgical interven- nous sedation with fentanyl and midazolam prior to abla-
tion also has some disadvantages such as leaving scar tissue tion. In two other studies [27,28], patients were just
in the neck. It also calls for a nonsurgical, minimally invasive prescribed local anesthesia in the neck. This change may
alternative for these patients who do not want to have sur- have been due to the accumulative experience that showed
gery. Ethanol ablation [22,23] and laser ablation [24] have that the possible local discomfort is only minimal, so
been tried previously in such scenarios. Radiofrequency has generalized anesthesia is usually not necessary. The ablation
also been introduced to ablate malignancy and begin thyroid power, which was only available from Park et al [27] and
nodules. In 1998, the first paper about radiofrequency Baek et al [28], was relatively low at 10e90 W, as compared
ablation in thyroid disease was published by Solbiati et al [1]. with that of ablation in hepatocellular carcinoma. The
Since that time, several papers had been published about ablation time, which ranged from 2 minutes to 15 minutes in
the efficacy for radiofrequency in thyroid glands. We review these four studies without much difference, was usually less
the literature about radiofrequency ablation in thyroid than that in ablation for hepatocellular carcinoma. All of
nodules. In reviewing the published literature, most authors these points show that ablation in liver and thyroid gland is
have reported that radiofrequency ablation is both effective not the same because the thyroid is smaller than the liver.
and safe when used to treat either benign thyroid nodules or Recurrent thyroid malignancy is also smaller as compared
recurrent thyroid cancer. By searching on PubMed, there with hepatocellular carcinoma. In the thyroid surgical bed or
were four articles about radiofrequency ablation in recur- local lymph nodes, they almost have no safety margins. For
rent thyroid cancer, which included more than eight pa- that reason, we need a smaller electrode tip, lower power
tients. There were also nine articles about radiofrequency output, and less ablation time to control so that the exact
Radiofrequency Ablation in Nodular Goiters 65
ablation zone is just adequate to kill the tumor without gland to ablate the nodules. By contrast, studies from Korea
damaging the surrounding tissue. With regard to complica- have used the Radionics Cool-tip ablation system with an
tions, all have reported good safety except for minor local internally cooled electrode. Most of these studies also intro-
neck pain after ablation. Dupuy et al [25] and Monchic et al duced a transisthmus approach with moving-shot technique
[26] have reported two cases of vocal cord paralysis and to treat larger tumors. As in a published consensus statement
Baek et al has reported one [28]. from the Korean Society of Radiology [39], this ablation
Another interesting difference among these studies is the technique has become a standard procedure in Korea.
ablation approach and technique. Park et al [27] and Baek All nine of these studies only gave local anesthesia in the
et al [28] introduced a transisthmus approach with a moving- neck, except for Kim et al [29], who administered intra-
shot technique to ablate larger tumors. It was first described venous sedation to 77% of the patients. The power output
for ablation of benign thyroid nodules [29,30], and is different was not available from the studies of Deandrea et al [32]
from the fixed-electrode technique, which has been used to and Spiezia et al [33]. With the fixed-needle technique,
ablate liver tumors. The transisthmus approach means to the nodules from these two studies were heated to
insert the electrode from the isthmus to the lateral aspect of 95e105 C for 10 minutes. The result of the volume
a targeted nodule. In that way, the electrode and whole reduction rate in the follow-up period of up to 2 years was
ablation course can be monitored by a transverse ultrasound reported as 47.7% by Deandrea et al and 79.4% by Spiezia
view. The moving-shot technique means that ablation can be et al. Deandrea et al also showed a little more effective-
performed by continuously moving the electrode forward, ness in volume reduction of hot nodules than cold ones
backward, upward, and downward to an untreated area. In (48.4% vs. 44.7%). Some patients who had hot nodules could
that way, Baek et al [30] have reported better ablation effi- be free from antithyroid drugs after ablation. The
cacy with a lower complication rate. improvement rate in the thyroid function test was reported
Although the results of radiofrequency ablation in as 31% by Deandrea et al and 79% by Spiezia et al.
recurrent thyroid cancer are promising, there were several The power output and ablation time in seven studies
limitations to these studies, including the small number of conducted in Korea [29,30,34e38] ranged from 20 W to
patients (only 45 in total) and the short follow-up period 120 W and up to 30 minutes. It took more time for the
(average, w2 years after ablation). There have been no moving-shot ablation technique because this technique di-
prospective randomized studies of radiofrequency ablation. vides thyroid nodules into multiple small conceptual abla-
The long-term survival benefit after ablation is not clear, so tion units and performs ablation unit-by-unit by moving the
further long-term follow-up studies are necessary to electrode. Theoretically, this technique will ablate nodules
determine the precise role of this therapy if it is to play an more completely because the tumor shape is usually ellip-
important role in the treatment of recurrent well- soid rather than round [40]. After a mean follow-up period of
differentiated thyroid cancer, and whether certain more around 12 months (up to 41 months), these studies showed a
invasive surgical procedures can be replaced. The summary better volume reduction rate, ranging from 75% to 92%, with
of all these four studies are shown in Table 1 [25e28]. a slightly better result in cystic nodules than solid ones. The
autonomously functioning nodules also showed improve-
ment in the thyroid function test and radioiodine scan, and
Radiofrequency ablation in benign thyroid four of nine patients had cold nodules and seven of nine
nodules patients became nearly euthyroid [34]. It is worth
mentioning that Baek et al [36] conducted a prospective
It is not always necessary for benign nodules to undergo study that compared the efficacy of radiofrequency ablation
surgery. However, when large nodules cause local versus control conditions. The control group had no resolu-
compression or cosmetic problems, they need further tion of nodule volume but increased slightly after 6 months.
treatment to relieve these symptoms. Levothyroxine sup- In the radiofrequency ablation group, mean nodule volume
pression therapy is a popular choice, but the outcome is not decreased from 7.5 mL to 1.3 mL after 6 months follow-up.
satisfactory, especially in larger nodules [31]. Therefore, Another study [37] has demonstrated that radiofrequency
other treatment modalities such as thermal ablation or ablation for predominantly cystic nodules is as effective as
ethanol injection have been attempted in many studies to ethanol ablation (average volume reduction at last follow-
reduce nodular volume. up, 92%). However, because ethanol ablation is much less
There are more academic reports about radiofrequency expensive than radiofrequency ablation, the authors have
ablation for benign thyroid lesions than for malignant ones suggested that ethanol ablation should be the first-line
(Table 2) [29,30,32e38]. The characteristics of the nodules treatment for predominantly cystic nodules.
ranged from purely cystic nodules and mixed nodules to solid The complications reported by Deandrea et al and Spiezia
ones. Both autonomous functioning (hot) nodules and cold et al were only minor local pain and edema after ablation,
nodules were included among these trials, although not in which could be controlled easily by acetaminophen and
every report. The volume of target nodules was also larger betamethasone, if necessary [32]. Oral antibiotics were not
than that of malignant ones, ranging from 6 mL to 25 mL. routinely administered after the procedure. Some patients
Interestingly, almost all of these papers came from two had fever up to 38.8 C after ablation, which however
countries: Italy [32,33] and Korea [29,30,34e38]. They used spontaneously returned to normal around 1 day after abla-
different ablation systems and different approaches to erase tion [33]. Major complications such as recurrent laryngeal
thyroid nodules. Deandrea et al [32] and Spiezia et al [33] nerve injury, cutaneous burning, local infection or damage
have used the RITA Starburst ablation system with hook- to the vital structures of the neck, and severe damage
expandable electrodes, via the longest axis of the thyroid induced along the needle track were not observed. Hot
66
Table 1 Summary of studies about radiofrequency ablation in recurrent thyroid cancer.
Researcher Dupuy et al [25] Monchik et al [26] Park et al [27] Baek et al [28]
Year of publication 2001 2006 2011 2011
Tumor type Recurrent WTC in neck Recurrent WTC in neck Recurrent WTC in neck Recurrent WTC in neck
No. of pts 8 16 16 recurrent sites in 11 patients 12 recurrent sites in 10 patients
Baseline nodule Diameter 2.4 cm Diameter 1.7 cm Diameter 2.9 cm; volume 9 mL Diameter 1.38 cm; volume
size, mean 55.5 mm3
Premedication IV sedation (fentanyl IV sedation (fentanyl Local anesthesia (xylocaine) Local anesthesia (xylocaine)
and midazolam) and midazolam)
Approach Unavailable Unavailable Transisthmus or vertical Transisthmus or vertical
Ablation technique Fixed-needle Fixed-needle Moving-shot Moving-shot for large tumor;
fixed-needle for small tumor
Generator Radionics Cool-tip system Radionics Cool-tip system Radionics Cool-tip system Radionics Cool-tip system
Electrode 18G, 1 cm, 2 cm active tip 18G, 1 cm, 2 cm active tip 18G, 0.5 cm, 1 cm, 1.5 cm, 18G, 0.5 cm, 1 cm active tip
2 cm active tip
Mode Unavailable Unavailable Unavailable Unavailable
Power output Unavailable Unavailable Mean 67.3 W Mean 14.7 W
Range 30e90 W Range 10e40 W
Ablation time 2e12 min 2e12 min Mean 11.7 min Mean 6.7 min
Range 1e22 min Range 1e15 min
Follow-up period Mean 10.3 mo Mean 40.7 mo Mean 6 mo Range 12e24 mo
Range 1e14 mo
Results (1) 6 of 8 pts: decreased serum (1) 11 of 16 pts: (1) Average volume reduction, 50.9% (1) Average volume reduction,
thyroglobulin level decreased serum (2) 7 of 11 pts (63.6%) relieved 89.7%
(2) 6 of 8 pts: thyroglobulin level local compressive symptoms (2) Average largest diameter
no evidence of recurrence in (2) 14 of 16 pts: no reduction 76.1%(3) Thyroglobulin
the treated LNs histologically recurrent disease decreased in 7 of 10 pts
(3) No recurrent disease in
100% pts
Complication 1 vocal cord paralysis 1 permanent vocal No reported major complications 1 dysphonia
1 minor skin burn cord paralysis
67
68
Table 2 (continued)
Baek et al [34] Lee et al [35] Baek et al [36] Sung et al [37] Hun et al [38]
2009 2010 2010 2011 2012
Hot nodules (solid Benign cold nodules (solid Benign cold nodules Benign cystic nodules Benign cystic nodules (solid
component 60e100%) component 10e50%) (solid component >50%) (solid component <10%) component >50%)
9 pts 27 pts (post-EA 1e2 mo) 15 pts 21 pts 30 pts (15 for 1 session, 15
for 2 sessions)
Volume 14.98 mL Volume 4.2 mL (after EA but Volume 7.5 mL Volume 10.19 mL Volume 13 mL (similar in
prior to RFA) 2 groups)
Local anesthesia (xylocaine) Local anesthesia (xylocaine) Local anesthesia (xylocaine) Local anesthesia Local anesthesia (xylocaine)
(xylocaine)
Transisthmus approach Transisthmus approach Transisthmus approach Transisthmus approach Transisthmus approach
Moving-shot Moving-shot Moving-shot Moving-shot Moving-shot
Radionics Cool-tip system Radionics Cool-tip system Radionics Cool-tip system Radionics Cool-tip system Radionics Cool-tip system
17G, 18G, 1 cm active tip 18G, 1 cm active tip 18G, 1 cm active tip 18G, 1 cm active tip 17G, 18G, 1 cm, 1.5 cm active tip
Unavailable Unavailable Unavailable Unavailable Unavailable
Range 30e80 W Range 20e70 W Mean 32.4 W Range 30e100 W Range 30e120 W
Range 30e80 W
Range 5e22 min Range 5e30 min Mean 15.5 min Range 3e32 min Unavailable
Range 6e17 mo Mean 21.2 mo Range 6e8 mo Mean 19.5 mo Mean 6 mo
Range 6e38 mo
(1) Average volume Average volume reduction afterAverage volume reduction Average volume Average volume reduction after
reduction at last additional RFA, 88% after 6 mo, 83% reduction at last 1 session, 70.2%/2 sessions, 78.3%
follow-up, 75% follow-up, 92% (but no statistic significance)
(2) 4 of 9 pts had
cold nodules
(3) 7 of 9 pts became
nearly euthyroid
No reported major complications No reported major complications No reported major complications No reported major complications No reported major complications
EA Z ethanol ablation; RFA Z radiofrequency ablation.
[23] Lewis BD, Hay ID, Charboneau JW, et al. Percutaneous ethanol [33] Spiezia S, Garberoglio R, Milone F, et al. Thyroid nodules
injection for treatment of cervical lymph node metastases in and related symptoms are stably controlled two years
patients with papillary thyroid carcinoma. Am J Roentgenol after radiofrequency thermal ablation. Thyroid 2009;19:
2002;178:699e704. 219e25.
[24] Dossing H, Bennedbaek FN, Karstrup S, et al. Benign solitary [34] Baek JH, Moon WJ, Kim YS, et al. Radiofrequency ablation for
solid cold thyroid nodules: US-guided interstitial laser photo- the treatment of autonomously functioning thyroid nodules.
coagulation e initial experience. Radiology 2002;225:53e7. World J Surg 2009;33:1971e7.
[25] Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency [35] Lee JH, Kim YS, Lee D, et al. Radiofrequency ablation (RFA) of
ablation of regional recurrence from well-differentiated thy- benign thyroid nodules in patients with incompletely resolved
roid malignancy. Surgery 2001;130:971e7. clinical problems after ethanol ablation (EA). World J Surg
[26] Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency 2010;34:1488e93.
ablation and percutaneous ethanol injection treatment for [36] Baek JH, Kim YS, Lee D, et al. Benign predominantly solid
recurrent local and distant well-differentiated thyroid carci- thyroid nodules: prospective study of efficacy of sono-
noma. Ann Surg 2006;244:296e304. graphically guided radiofrequency ablation versus control
[27] Park KW, Shin JH, Han BK, et al. Inoperable symptomatic condition. AJR Am J Roentgenol 2010;194:1137e42.
recurrent thyroid cancers: preliminary result of radio- [37] Sung JY, Kim YS, Choi H, et al. Optimum first-line treatment
frequency ablation. Ann Surg Oncol 2011;18:2564e8. technique for benign cystic thyroid nodules: ethanol ablation
[28] Baek JH, Kim YS, Sung JY, et al. Locoregional control of meta- or radiofrequency ablation? AJR Am J Roentgenol 2011;196:
static well-differentiated thyroid cancer by ultrasound-guided W210e4.
radiofrequency ablation. Am J Roentgenol 2011;197:W331e6. [38] Huh JY, Baek JH, Choi H, et al. Symptomatic benign thyroid
[29] Kim YS, Rhim H, Tae K, et al. Radiofrequency ablation of nodules: efficacy of additional radiofrequency ablation
benign cold thyroid nodules: initial clinical experience. Thy- treatment session e prospective randomized study. Radiology
roid 2006;16:361e7. 2012;263:909e16.
[30] Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of [39] Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of
benign thyroid nodules: safety and imaging follow-up in 236 benign thyroid nodules and recurrent thyroid cancers:
patients. Eur Radiol 2008;18:1244e50. consensus statement and recommendations. Korean J Radiol
[31] Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in 2012;13:117e25.
nodular goiter: a 5-year prospective randomized trial of lev- [40] Baek JH, Lee JH, Valcavi R, et al. Thermal ablation for benign
othyroxine suppressive therapy for benign cold thyroid nod- thyroid nodules: radiofrequency and laser. Korean J Radiol
ules. J Clin Endocrinol Metab 1998;83:780e3. 2011;12:525e40.
[32] Deandrea M, Limone P, Basso E, et al. US-guided percutaneous [41] Baek JH, Lee JH, Sung JY, et al. Complications encountered in
radiofrequency thermal ablation for the treatment of solid the treatment of benign thyroid nodules with US-guided
benign hyperfunctioning or compressive thyroid nodules. Ul- radiofrequency ablation: a multicenter study. Radiology
trasound Med Biol 2008;34:784e91. 2012;262:335e42.